BeyondSpring Inc.
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
BYSI | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG108301006
- LEI:
- Country:
- United States of America
- Address:
- 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, 7932 FLORHAM PARK
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BeyondSpring Inc. is a global, clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies. The company is committed to improving clinical outcomes and raising the standard of care for cancer patients. Its lead asset, Plinabulin, is being developed as a 'pipeline in a drug' for multiple cancer indications. BeyondSpring is also an equity owner of SEED Therapeutics, a company specializing in Targeted Protein Degradation (TPD) technology to discover and develop novel 'molecular glues' for breakthrough therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BeyondSpring Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BeyondSpring Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BeyondSpring Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
